Admissions to hospital of 171 children with sickle-cell anaemia, genotype Hb SS, were reviewed over a 20-year period. Altogether 887 admissions occurred in 797 patient-years. The commonest cause of admission was painful vaso-occlusive crisis. Appreciable morbidity also resulted from pulmonary disease, infection, and anaemic episodes. The complications resulting in the most severe illness were acute splenic sequestration, pneumococcal meningitis, and some episodes of erythroid hypoplasia resulting in very low haemoglobin concentrations. Most deaths occurred in children aged under 5. Mortality and morbidity could be reduced by measures including prophylaxis of pneumococcal infections and more active treatment of seemingly minor illness in children with sickle-cell anaemia.
Introduction
In Britain the number of children with sickle-cell anaemia has gradually increased over the past 20 years. This condition is most likely to be encountered here in those of Caribbean or African descent, and in such children we have found a carrier rate of 8 7% and 17 6% respectively. So far there has been no account of the pattern of morbidity of sickle-cell anaemia in children in Britain.
Methods
We reviewed the hospital admission records of children aged 1 month to 17 years who attended the Belgrave Children's and King's College Hospitals between 1 January 1960 and 31 December 1979 to define the most common and the most serious complications. All patients were homozygous for haemoglobin S (Hb S) so far as could be ascertained, complete family studies not always being available to differentiate any case of Hb S ,B'-thalassaemia. Applying known frequency rates for a sample of the size studied, 13 cases of Hb S ,B-thalassaemia would be expected. Nine cases of Hb S ,B+-thalassaemia were identified in patients not included in this study. There were 887 admissions in all (table I) . The number of admissions per patient varied widely; 17 patients aged from 1 month to 17 years (median 18 months) had no admissions, while a boy of 14 had 53. In the 113 patients whose complete medical history was known the mean number of admissions per year of age ranged from 0 to 3 79 (median 0 53). Other proved bacterial infections were pertussis (1), Escherichia coli urinary infection (1) , and streptococcal tonsillitis (1) . In five cases of apparent bacterial infection no organism was isolated (meningitis where penicillin had already been given (1), osteomyelitis diagnosed on clinical and radiological grounds (1), and tonsillitis (3) (table III) accounted for 213 (24,'0 ) admissions, the aim being to keep the haemoglobin concetstration above 11 g/dl, thus suppressing marrow production of Hb S-containing cells. Sixty-three transfusions were for medical reasons such as chronic bone disease of the spine or femoral head, hemiparesis, pulmonary tuberculosis, chronic ill-health, and impaired growth; thirty-eight preceded surgery; and 60 were given as prophylaxis against crises during air travel. An additional five children with persistent pronounced splenomegaly associated with severe anaemia received 52 transfusions over several months before splenectomy.
PULMONARY INVOLVEMENT
Pulmonary involvement confirmed by radiography or scan, or both, led to 74 (8-3 0() admissions in children aged 9 months to 15 years ( fig 2) . It is difficult to differentiate between so-called infarction and infection in sickle-cell anaemia. 1 Pneumococcus was cultured from the throat swab in three cases, and Haemophilus influenzae from the sputum in one. Two children had pulmonary tuberculosis. One child had a pulmonary abscess, but no organism was isolated. In the other 67 episodes no pathogen was found, but in five there was coryza and in one an axillary abscess. Other complications of sickle-cell anaemia often accompanied lung disease: skeletal pain was present in 17, epistaxis in two, and in one case with skeletal pain, fat was found in the sputum.
ANAEMIC EPISODES
Anaemic episodes, defined as a drop in haemoglobin from the known steady-state concentration, were considered an immediate indication for admission because of the danger of hypoplastic or sequestration crises. Of 67 such admissions, as indicated by manual haemoglobin screening, 15 proved unnecessary on repeat measurement.
Splenic sequestration with a rapid fall of haemoglobin to concentrations of 2 There were two episodes of biliary colic. Another two children presented with enlarged tender livers six days and three weeks after transfusion; serology for hepatitis B was performed in one and proved negative. In all these episodes liver enzymes were severely abnormal; abnormal liver enzymes were also found in two children admitted with upper respiratory symptoms.
CENTRAL NERVOUS SYSTEM
Central nervous system complications precipitated seven admissions. Three episodes of hemiparesis occurred in two patients at 5, 6, and 10 years of age, one after an upper respiratory infection and another joint pain. A series of convulsions occurred in an 8 year old after a minor head injury and a 6 year old had an isolated convulsion with fever due to tonsillitis. Another child went into coma for 24 hours after a convulsion and then recovered completely. An 18-month-old child died with cerebral oedema due to intracranial sickling during a febrile illness.
OTHER COMPLICATIONS There were several admissions for miscellaneous complications such as vague ill-health (7), epistaxis (6), chronic bone disease (6), nephrotic syndrome (1), haematuria (1) , and eye pain accompanied by loss of vision lasting 10 minutes (1).
Four children were admitted on five occasions with haemoglobinuria six to 13 days after transfusion with rhesus-positive blood. Anti-E was detected in two of these children, one Splenic sequestration, where a rapid fall in haemoglobin occurs with sudden splenic (and sometimes hepatic) enlargement and hypovolaemic shock, is a potent cause of death in young children with sickle-cell anaemia.7 Infection, often pneumococcal, has been implicated in some cases.8 9 None of our six patients had pneumococcal infection. Erythroid hypoplasia was probably more common than it appeared, as apart from seven definite cases a further 32 were probably recovering from an episode by the time they were seen. A temporary fall in red cell production associated with infection is probably more common than is realised,'0 and its effect would be accentuated in patients with sickle-cell anaemia because of the short life span of their circulating red cells."' Functional asplenia12 and a deficiency in opsonisation"3 14 put children with sickle-cell anaemia at a greatly increased risk of pneumococcal infection, especially meningitis. '5 16 In some series pneumococcal meningitis has been noted to be more severe in children with this disease than in other children, often with a rapid onset, few clinical signs, and only mild changes in cerebrospinal fluid. '6-'8 In the five patients with proved pneumococcal meningitis in our series all had been unwell in some way for three or more days, and were noted to be ill, lethargic, or drowsy on admission, although two had no signs of meningeal irritation. White cell counts in the cerebrospinal fluid ranged from 0-056-5-4 X 109/l, with 60% or more neutrophils; cerebrospinal fluid protein and sugar abnormalities were not always present. Although all were severely ill, and one developed concurrent erythroid hypoplasia, none of these patients died. One remains retarded 10 years later, but the others have no long-term sequelae. It is important that three of these children were aged 15 months or younger (as was the additional patient with meningitis who had received penicillin before lumbar puncture), an age at which there is doubt about the efficacy of pneumococcal vaccine.'9 20 Although all but one of these children were known to have sickle-cell anaemia, for various reasons none was receiving penicillin prophylaxis at the time. We have not seen pneumococcal infection in any child taking regular penicillin prophylaxis.
Haemoglobinuria after transfusion emphasises the importance of genotyping patients with sickle-cell anaemia before transfusion. In our experience about half of these children carry the genotype R0 (cDe) and if given rhesus (D)-positive blood may develop anti-C or anti-E.
Deaths have been mentioned, though not all occurred during an admission. They illustrate three points: five out of nine were under 5 years of age, most were sudden (four occurring outside hospital), and necropsies, including coroner's necropsies, were not always helpful in determining the exact cause of death.
The reduction of morbidity and mortality in sickle-cell anaemia demands careful follow-up of children in the early years of life and prompt attention in the first 24 hours of admission, even with seemingly minor illness. Prophylaxis against pneumococcal infection by long-term penicillin as well as pneumococcal vaccine is indicated, especially as some deaths from pneumococcal infection occur before the age at which the vaccine is fully effective.7 (Accepted 15 January 1981)
A woman was given stilboestrol to suppress lactation when she was eight weeks pregnant. She probably received about 120 mg in 12 days. The girl who was born is now 12 years old and the mother is worried by reports she has read about an increased risk of cancer in the reproductive tract in girls whose mothers were given stilboestrol during pregnancy. What are the risks ?
It has been estimated that between 1940 and 1971 stilboestrol was given to about 7500 British women' and over a million American women to treat or "prevent" threatened abortion. A female fetus exposed to stilboestrol between weeks eight and 22 of pregnancy has an 80% chance of being born with benign vaginal epithelial changes2 -which, however, appear to regress with age and are found in only 34%/' of the 3000 at-risk women now being followed up in the United States. It is not known if these changes are premalignant but the risk of clear-cell adenocarcinoma of the vagina is about 0 14-1-14 per stilboestrol-exposed girls. In the United States over 200 cases of stilboestrol-associated vaginal cancer have occurred and one case has been reported in Britain.' Possibly up to 10 more cases are awaiting discovery here. The symptoms of vaginal cancer are abnormal bleeding or blood-stained discharge and young women with such symptoms should be examined carefully. Cases can be diagnosed early at an asymptomatic stage, and at-risk women should have six-monthly pelvic examination, cervical smear, and colposcopy, with biopsy of suspicious areas. Cytology of vaginal aspirate and iodine staining have also been recommended.1 The peak incidence of vaginal carcinoma is at age 19, but the duration of follow-up required is not yet known. A recent report3 also suggests that these patients have a higher risk of premature labour (but not of other pregnancy complications) and so close antenatal supervision is indicated. On a more optimistic note there is evidence that some at least of these risks are dose-related, and since this particular patient had a relatively brief exposure to stilboestrol, she may be at less risk. 
